Showing results (221-230 of 242) with videos related to
Sort By:
Pageof 25
Cancer Chemotherapy and Pharmacology|January 23, 2013
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance markerMasahiro Hirakawa, Yasushi Sato, Hiroyuki Ohnuma, et al.European Journal of Gastroenterology & Hepatology|March 23, 2026
Long-term effects of L-carnitine on hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis: a multicenter retrospective studyJoji Tani, Akio Moriya, Tetsu Tomonari, et al.Gut|November 19, 2024
Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre studyJinsei Miyoshi, Alessandro Mannucci, Marco Scarpa, et al.Journal of Gastroenterology and Hepatology|November 14, 2025
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular CarcinomaTakanori Ito, Shigeo Shimose, Issei Saeki, et al.International Journal of Clinical Oncology|June 29, 2021
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal CancerNaohiro Tomita, Hideyuki Ishida, Kohji Tanakaya, et al.International Journal of Clinical Oncology|February 2, 2022
Cancer risk and genotype-phenotype correlation in Japanese patients with Cowden syndromeSatoshi Teramae, Naoki Muguruma, Koichi Okamoto, et al.Endoscopy|October 10, 2022
Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis (J-FAPP Study III): a multicenter prospective interventional studyHideki Ishikawa, Masayoshi Yamada, Yasushi Sato, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2025
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class BRyu Sasaki, Shigeo Shimose, Issei Saeki, et al.Oncology Letters|July 9, 2024
Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practiceShigeo Shimose, Issei Saeki, Tetsu Tomonari, et al.Artificial Organs|March 19, 2020
Development of a novel automatic ascites filtration and concentration equipment with multi-ring-type roller pump units for cell-free and concentrated ascites reinfusion therapyToshiya Okahisa, Masahiro Sogabe, Tadahiko Nakagawa, et al.Pageof 25